BioSpace News Archive

ASLAN Pharmaceuticals, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced that Dr Carl Firth, CEO, is scheduled to give a company presentation at the H.C. Wainwright Bioconnect Conference on January 10, 2022.

Cyclacel Pharmaceuticals, Inc. today provided a business update reviewing 2021 achievements and outlining the Company’s key business objectives for 2022.

CNS Pharmaceuticals, Inc. announced today that it has entered into securities purchase agreements with several institutional and accredited investors.

Odyssey Therapeutics announced that it has acquired Rahko, a leading quantum machine learning company, adding powerful new tools to Odyssey’s discovery platform to enable faster and more efficient drug discovery.

Pillar Biosciences today announced that its NGS laboratory, located in Natick, Massachusetts, has passed the onsite inspection and received Clinical Laboratory Improvement Amendment (CLIA) certification from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS).

The growth in the global small scale bioreactors market has been possible with the growing use of single use bioreactors.

Competition in the global multiplex assays market is likely witness high growth, as players are focusing in different organic and inorganic business development activities.

In their latest report titled – “Medical Tubing Packaging Market - Global Industry, Size, Share, Growth, Trends and Forecast, 2018–2026”, Transparency Market Research delivers key insights on the use of different materials and processes used for medical tubing, along with various end uses and applications.

Transparency Market Research has published a new report titled, ‘Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Major advancements in medical science and technology, coupled with the increasing adoption of personalized medicine initiatives are likely to aid in expansion of the global DNA & RNA banking services market during the forecast period set between 2020 and 2030.